Imaging Biomarkers in Acute Ischemic Stroke Trials: A Systematic Review [RESEARCH PERSPECTIVES]

CONCLUSIONS: Imaging biomarkers offer the opportunity to refine the trial cohort by minimizing participant variation, to decrease sample size, and to personalize treatment approaches for those who stand to benefit most. However, within imaging modalities, there has been little consistency between stroke trials. Greater effort to prospectively use consistent imaging biomarkers should help improve the development of novel treatment strategies in acute stroke and improve comparison between studies.
Source: American Journal of Neuroradiology - Category: Radiology Authors: Tags: RESEARCH PERSPECTIVES Source Type: research